Literature DB >> 23303419

Exacerbation of auditory verbal hallucinations with adjunctive high-frequency cerebellar vermal repetitive transcranial magnetic stimulation in schizophrenia: a case report.

Shobit Garg1, Nishant Goyal, Sai Krishna Tikka, Vinod Kumar Sinha.   

Abstract

In schizophrenia, novel target sites for repetitive transcranial magnetic stimulation (rTMS), such as the cerebellum, are proposed to have a putative therapeutic role in treatment-resistant cases. We present a case of treatment-resistant schizophrenia that showed worsening of auditory verbal hallucinations after receiving high-frequency cerebellar vermal rTMS. We propose that cerebellar vermal rTMS modulates neuronal networks, causing activation in temporoparietal areas, which results in worsening of auditory verbal hallucinations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303419     DOI: 10.1097/YCT.0b013e3182706aa1

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  4 in total

1.  Cerebellar Contributions to Persistent Auditory Verbal Hallucinations in Patients with Schizophrenia.

Authors:  Maximilian Cierpka; Nadine D Wolf; Katharina M Kubera; Mike M Schmitgen; Nenad Vasic; Karel Frasch; Robert Christian Wolf
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

2.  Anatomical Association Between Schizophrenia and Cerebellum.

Authors:  Rajashekar Reddy Yeruva; Yafei Shang; Ben Schoenbachler; Sharon Nuss; Rif S El-Mallakh
Journal:  Innov Clin Neurosci       Date:  2021 Jul-Sep

3.  Altered resting-state functional connectivity of the cerebellum in schizophrenia.

Authors:  Chuanjun Zhuo; Chunli Wang; Lina Wang; Xinyu Guo; Qingying Xu; Yanyan Liu; Jiajia Zhu
Journal:  Brain Imaging Behav       Date:  2018-04       Impact factor: 3.978

4.  Efficacy of Intensive Cerebellar Intermittent Theta Burst Stimulation (iCiTBS) in Treatment-Resistant Schizophrenia: a Randomized Placebo-Controlled Study.

Authors:  Preeti Chauhan; Shobit Garg; Sai Krishna Tikka; Sumit Khattri
Journal:  Cerebellum       Date:  2020-09-22       Impact factor: 3.847

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.